Spelling typos are one thing but you have said some really stupid things today that hedge would have never said.
you have done extensive DD on the take under. How is it financed and by whom. Surely that is step one in creating a theory?
correct sharon he got me also It is so sad he needs to fake his ID because none want any part of this poor pathtic little boy
"we expect Eisai to submit an application for regulatory approval of BELVIQ in Brazil by around the end of 2013.
we expect Ildong to submit an application for regulatory approval of BELVIQ by around the end of 2013.
We also expect CYB to submit an application for regulatory approval of BELVIQ in Taiwan by around the end of 2013.
[before the end of 2013]...we also expect to receive from Eisai a $60.0 million upfront payment in connection with the establishment of the Eisai Second Amended Agreement, additional payments for purchases of BELVIQ product supply and a milestone payment of $0.5 million in connection with the planned filing of an application for regulatory approval of BELVIQ in Brazil.
we expect Eisai to initiate a 12-week, double-blind, randomized, parallel-group pilot study by around the end of 2013 to evaluate short-term safety and tolerability of lorcaserin 10 mg twice daily by itself and when administered in combination with phentarhino
We expect Ildong to initiate such Phase 1 trial by around the end of 2013 to evaluate the safety of co-administration of temanogrel with aspirin and clopidogrel.
Eisai Will Double BELVIQ® (lorcaserin HCl) CIV Sales Force by December, which will increase their reach to 65,000 physicians by the end of the year.
Selection of lorcaserin 20 milligram extended release tablet from September study.
The Obesity Society's Obesity Week 2013
BELVIQ data will be presented at the American Heart Association Scientific Sessions, in Dallas November 16th through November 20th.
Arena presentation at the Piper Jaffray 19th annual Health Care Conference in New York, Nov. 27-29.
The cardiovascular outcome trial will be an international trial with substantial numbers of patients over up to five or six years. And we’ll of course focus on ruling out harm, but the trial will also have the opportunity to look at benefit for cardiovascular outcomes and we hope to begin this trial around the end of this year"
Thanks to Suave9
This post was not about an up day. It was about the stock price going up. There is a difference. Yes, I did think early in the day that the stock price would reverse sooner than it did.
You're kidding, right? NOW PUT YOUR HEAD DOWN AND TAKE A NAP!!!!
My crystal ball notwithstanding, intraday turnaround as predicted occurred and you will see higher pps all week. If you read what I wrote, the pps will be week due to those holidays, as it was for the Thanksgiving week. 2014 will be a big winner for arena probably as big as it was in 2012.
You're right and Spencer O set this scenario up w/ his article last week. He said that the large investment houses would sell high and buy low based upon the short work week (causing low scripts). Inexperienced traders have this upside down. They are trying to sell now -Hoping that the price will fall later in the week based on anticipated low script. But it's upside down. If you didn't sell before the script numbers came out on Friday you should wait. The script numbers for this week will increase until the short Christmas week and then lower again. If you sell now, you'll lose money
xplay...a one time div is not happening.. lets get a jolt from other areas to get the ball rolling...it should come soon...
Sentiment: Strong Buy